Effect of Bevacizumab, Which Remain After Withdrawal of the First Dose/S From a Single-Use Vial on Diabetic Macular Edema

International Journal of Basic & Clinical Pharmacology
doi 10.5455/2319-2003.ijbcp20150233
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medip Academy

Related search

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

The Effect of Photocoagulation in Ischemic Areas to Prevent Recurrence of Diabetic Macular Edema After Intravitreal Bevacizumab Injection

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2014English

Effect of Ripasudil on Diabetic Macular Edema

Scientific Reports
Multidisciplinary
2019English

Effect of Initial Retinal Thickness on Outcome of Intravitreal Bevacizumab Therapy for Diabetic Macular Edema

Clinical Ophthalmology
Ophthalmology
2014English

Effect of Intravitreal Triamcinolone Acetonide or Bevacizumab on Choroidal Thickness in Eyes With Diabetic Macular Edema

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2014English

Short Term Effect of Intravitreal Bevacizumab for Diabetic Macular Edema Associated With Epiretinal Membrane

Romanian journal of ophthalmology
Medicine
2018English

Effect of Intravitreal Aflibercept on Recalcitrant Diabetic Macular Edema

International Journal of Retina and Vitreous
Ophthalmology
2017English

Intravitreal Bevacizumab Injections for Diabetic Macular Edema &Ndash; Predictors of Response: A Retrospective Study

Clinical Ophthalmology
Ophthalmology
2016English

Short Term Results After Single Dose Intravitreal Bevacizumab Treatment for Macular Edema Secondary to Central and Branch Retinal Vein Occlusions

Southern Clinics of Istanbul Eurasia
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy